KRN7000 applied to AIDS research

Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens

Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide

Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells.

CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection

Adjuvant Effects of an NKT Ligand, alpha-Galactosylceramide, on DNA Vaccination

 

Meet Funakoshi Company

Please visit our booth at one of these 2012 meetings:

AACR
Booth# 333
April 1-4, 2012

NIH Spring Festival
Booth# 903
April 25-26, 2012